See more : Finexia Financial Group Limited (FNX.AX) Income Statement Analysis – Financial Results
Complete financial analysis of ageas SA/NV (AGESY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ageas SA/NV, a leading company in the Insurance – Diversified industry within the Financial Services sector.
You may be interested
- Bajaj Electricals Limited (BAJAJELEC.NS) Income Statement Analysis – Financial Results
- Pangenomic Health Inc. (NARA.CN) Income Statement Analysis – Financial Results
- Ambalal Sarabhai Enterprises Limited (AMBALALSA.BO) Income Statement Analysis – Financial Results
- AP Holdings Co.,Ltd. (3175.T) Income Statement Analysis – Financial Results
- Premier Products Group, Inc. (PMPG) Income Statement Analysis – Financial Results
ageas SA/NV (AGESY)
About ageas SA/NV
ageas SA/NV, together with its subsidiaries, engages in insurance business in Europe and Asia. The company primarily offers property, casualty, and life insurance products, as well as pension products; and reinsurance products. Its life insurance products include risks related to the life and death of individuals; and non-life insurance products comprise accident and health, motor, fire, and other insurance products, as well as other damages to property covering the risk of property losses or claims liabilities. The company serves private individuals, as well as small, medium-sized, and large companies through independent brokers and the bank channels. ageas SA/NV was founded in 1824 and is headquartered in Brussels, Belgium.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.53B | 9.58B | 13.04B | 11.63B | 14.19B | 11.03B | 11.85B | 13.45B | 13.17B | 13.43B | 13.11B | 14.56B | 12.22B | 13.63B | 15.78B | 9.57B | 118.92B | 94.36B | 90.42B | 54.59B | 50.10B |
| Cost of Revenue | -3.72B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 11.25B | 9.58B | 13.04B | 11.63B | 14.19B | 11.03B | 11.85B | 13.45B | 13.17B | 13.43B | 13.11B | 14.56B | 12.22B | 13.63B | 15.78B | 9.57B | 118.92B | 94.36B | 90.42B | 54.59B | 50.10B |
| Gross Profit Ratio | 149.36% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 24.00M | 144.00M | 121.00M | 126.00M | 165.40M | 139.80M | 137.70M | 146.10M | 131.20M | 108.10M | 104.70M | 111.90M | 103.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 65.00M | 62.00M | 62.00M | 60.00M | 67.50M | 55.60M | 58.00M | 69.30M | 78.10M | 73.50M | 74.40M | 83.40M | 79.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 89.00M | 206.00M | 183.00M | 186.00M | 232.90M | 195.40M | 195.70M | 215.40M | 209.30M | 181.60M | 179.10M | 195.30M | 182.30M | 0.00 | 0.00 | 644.00M | 4.98B | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 9.76B | -8.38B | -12.72B | -10.95B | -13.85B | -10.07B | -11.07B | -1.40B | -721.70M | -1.18B | -683.50M | -1.95B | -12.67B | -540.00M | -1.99B | 2.65B | -1.73B | -2.25B | -1.08B | 6.13B | -47.84B |
| Operating Expenses | 9.85B | -8.18B | -12.53B | -10.76B | -13.62B | -9.87B | -10.87B | -1.19B | -512.40M | -994.20M | -504.40M | -1.76B | -12.67B | -540.00M | -1.99B | 3.29B | 3.25B | -2.25B | -1.08B | 6.13B | -47.84B |
| Cost & Expenses | 9.85B | 8.13B | 11.80B | 10.10B | 12.76B | 9.78B | 10.74B | 13.01B | 12.00B | 12.63B | 12.12B | 13.30B | 12.98B | 13.49B | 14.15B | 10.05B | 116.10B | 88.92B | 85.27B | 50.70B | 47.84B |
| Interest Income | 0.00 | 1.89B | 1.84B | 1.86B | 1.93B | 1.99B | 2.10B | 2.30B | 2.39B | 2.40B | 2.44B | 2.50B | 3.09B | 3.01B | 3.12B | 3.09B | 94.87B | 72.58B | 66.84B | 41.19B | 26.69B |
| Interest Expense | 275.00M | 167.00M | 126.00M | 118.00M | 108.50M | 93.40M | 98.00M | 119.40M | 123.60M | 125.90M | 168.30M | 218.30M | 310.00M | 298.40M | 498.00M | 1.34B | 87.35B | 65.12B | 60.23B | 34.35B | 19.73B |
| Depreciation & Amortization | 299.00M | 284.00M | 181.00M | 180.00M | 175.50M | 110.40M | 110.50M | 209.40M | 749.40M | 951.40M | 793.70M | 798.70M | 686.90M | 606.90M | 575.00M | 375.00M | 805.00M | 832.00M | 967.40M | 791.80M | 19.73B |
| EBITDA | 557.00M | 2.28B | 1.34B | 1.72B | 1.23B | 1.83B | 1.72B | 1.11B | 1.87B | 1.69B | 1.78B | 2.10B | 199.10M | 1.05B | 2.72B | 1.24B | 2.21B | 71.33B | 66.34B | 39.37B | 21.99B |
| EBITDA Ratio | 7.40% | 23.82% | 10.25% | 14.79% | 8.69% | 16.60% | 14.53% | 8.23% | 14.19% | 12.59% | 13.56% | 14.41% | 1.97% | 7.68% | 17.13% | -273.64% | 77.29% | 75.60% | 6.71% | 72.12% | 43.89% |
| Operating Income | 1.40B | 1.41B | 503.00M | 866.00M | 579.30M | 1.16B | 979.40M | 434.70M | 1.17B | 793.00M | 993.00M | 1.52B | -446.80M | 425.30M | 1.18B | -504.00M | 2.83B | 68.33B | 5.15B | 32.11B | 2.25B |
| Operating Income Ratio | 18.54% | 14.68% | 3.86% | 7.45% | 4.08% | 10.47% | 8.26% | 3.23% | 8.85% | 5.91% | 7.57% | 10.46% | -3.66% | 3.12% | 7.47% | -5.26% | 2.38% | 72.41% | 5.70% | 58.82% | 4.50% |
| Total Other Income/Expenses | 32.00M | -5.44B | -11.24B | -9.44B | -12.33B | -9.43B | -10.51B | -11.92B | -11.40B | -12.37B | -11.35B | 416.80M | -756.80M | -284.10M | 451.00M | 27.00M | -2.71B | -62.94B | 0.00 | -29.22B | 0.00 |
| Income Before Tax | 1.43B | 1.45B | 1.23B | 1.53B | 1.43B | 1.25B | 1.11B | 434.70M | 1.17B | 793.00M | 993.00M | 1.27B | -756.80M | 141.20M | 1.63B | -477.00M | 2.83B | 5.44B | 5.15B | 3.89B | 2.25B |
| Income Before Tax Ratio | 18.97% | 15.15% | 9.44% | 13.18% | 10.09% | 11.33% | 9.35% | 3.23% | 8.85% | 5.91% | 7.57% | 8.70% | -6.19% | 1.04% | 10.33% | -4.98% | 2.38% | 5.77% | 5.70% | 7.13% | 4.50% |
| Income Tax Expense | 251.00M | 229.00M | 215.00M | 233.00M | 254.50M | 252.80M | 258.20M | 211.90M | 226.00M | 137.20M | 246.40M | 338.90M | -83.30M | -222.60M | 318.00M | 108.00M | -235.00M | 1.03B | 1.16B | 1.03B | 499.00M |
| Net Income | 953.00M | 1.10B | 845.00M | 1.14B | 979.00M | 809.10M | 623.20M | 27.10M | 770.20M | 475.60M | 569.50M | 743.00M | -673.50M | 363.80M | 1.33B | -28.02B | 3.99B | 4.35B | 3.94B | 3.20B | 1.76B |
| Net Income Ratio | 12.66% | 11.45% | 6.48% | 9.81% | 6.90% | 7.34% | 5.26% | 0.20% | 5.85% | 3.54% | 4.34% | 5.10% | -5.51% | 2.67% | 8.43% | -292.72% | 3.36% | 4.61% | 4.36% | 5.86% | 3.50% |
| EPS | 5.19 | 5.49 | 4.52 | 6.07 | 5.09 | 4.11 | 3.09 | 0.13 | 3.57 | 2.13 | 2.49 | 3.13 | -2.65 | 0.90 | 4.90 | -122.05 | 23.00 | 28.30 | 25.70 | 20.96 | 11.32 |
| EPS Diluted | 5.18 | 5.49 | 4.52 | 6.07 | 5.08 | 4.11 | 3.09 | 0.13 | 3.57 | 2.13 | 2.49 | 3.13 | -2.64 | 0.90 | 4.90 | -122.01 | 20.40 | 28.00 | 25.37 | 20.26 | 11.32 |
| Weighted Avg Shares Out | 183.67M | 184.16M | 186.77M | 187.94M | 192.53M | 196.78M | 201.77M | 208.52M | 215.54M | 223.06M | 228.74M | 237.45M | 254.61M | 248.23M | 247.50M | 229.59M | 173.60M | 154.00M | 153.25M | 152.52M | 155.07M |
| Weighted Avg Shares Out (Dil) | 183.82M | 184.32M | 186.91M | 188.10M | 192.60M | 196.93M | 201.99M | 208.93M | 216.13M | 223.63M | 229.26M | 237.67M | 254.67M | 248.24M | 247.55M | 229.66M | 201.19M | 158.53M | 158.25M | 157.78M | 155.07M |
AGESY or ZURVY: Which Is the Better Value Stock Right Now?
Investors interested in Insurance - Multi line stocks are likely familiar with Ageas SA (AGESY) and Zurich Insurance Group Ltd. (ZURVY). But which of these two stocks presents investors with the better value opportunity right now?
Should Value Investors Buy Ageas (AGESY) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...
Best Value Stocks to Buy for October 22nd
SOHO, HY and AGESY made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 22, 2024.
Best Value Stocks to Buy for October 11th
AGESY, CURV and MTG made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 11, 2024.
Best Income Stocks to Buy for October 11th
AGESY, AVNT and MTG made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 11, 2024.
New Strong Buy Stocks for October 11th
AGESY, INTA, STEP, CURV and MMS have been added to the Zacks Rank #1 (Strong Buy) List on October 11, 2024.
AGESY vs. ZURVY: Which Stock Is the Better Value Option?
Investors interested in Insurance - Multi line stocks are likely familiar with Ageas SA (AGESY) and Zurich Insurance Group Ltd. (ZURVY). But which of these two stocks offers value investors a better bang for their buck right now?
Should Value Investors Buy Ageas (AGESY) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...
Are Investors Undervaluing Ageas (AGESY) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...
AGESY or RDN: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Insurance - Multi line sector have probably already heard of Ageas SA (AGESY) and Radian (RDN). But which of these two stocks offers value investors a better bang for their buck right now?
Source: https://incomestatements.info
Category: Stock Reports